Krishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences Ltd (KIMS) last reported results for the quarter ended Jun 2026, with sales of ₹1,180 crore and net profit of ₹37 crore. Krishna Institute of Medical Sciences Ltd’s board meets on 31 Oct 2026. The stock last traded at ₹699, a market capitalisation of ₹29,377 crore, on a P/E of 141. Over the past 52 weeks the stock has ranged between ₹576 and ₹858. Figures are as of 6 Oct 2026 and are not real time.
Krishna Institute of Medical Sciences Ltd share price and key metrics
- Current price
- ₹699
- Market cap
- ₹29,377 cr
- Stock P/E
- 141
- Book value
- ₹56.2
- ROE
- 11.3%
- ROCE
- 9.50%
- Dividend yield
- 0.00%
- 52w high / low
- 858/576
Metrics as of 6 Oct 2026. Not real time.
Track Krishna Institute of Medical Sciences Ltd
Cruxal reads every Krishna Institute of Medical Sciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Krishna Institute of Medical Sciences Ltd growth and returns
- 10 Years
- 23%
- 5 Years
- 24%
- 3 Years
- 21%
- TTM
- 31%
- 10 Years
- 25%
- 5 Years
- 4%
- 3 Years
- -9%
- TTM
- -43%
- 10 Years
- %
- 5 Years
- 24%
- 3 Years
- 23%
- 1 Year
- -2%
- 10 Years
- 18%
- 5 Years
- 18%
- 3 Years
- 15%
- Last Year
- 11%
Krishna Institute of Medical Sciences Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹1,180 cr, up 35.3% from ₹872 cr a year earlier. Net profit was ₹37 cr, down 56.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 777 | 772 | 797 | 872 | 961 | 998 | 1,075 | 1,180 |
| Expenses | 559 | 585 | 599 | 679 | 757 | 799 | 868 | 956 |
| Operating profit | 218 | 187 | 198 | 193 | 204 | 199 | 206 | 223 |
| OPM % | 28% | 24% | 25% | 22% | 21% | 20% | 19% | 19% |
| Other income | 5 | 18 | 15 | 7 | 4 | 5 | 1 | 17 |
| Interest | 20 | 26 | 27 | 33 | 45 | 57 | 68 | 83 |
| Depreciation | 41 | 45 | 53 | 53 | 66 | 79 | 85 | 101 |
| Profit before tax | 162 | 135 | 134 | 114 | 97 | 69 | 55 | 57 |
| Tax % | 26% | 31% | 21% | 25% | 26% | 24% | 40% | 34% |
| Net profit | 121 | 92 | 106 | 85 | 72 | 52 | 33 | 37 |
| EPS (₹) | 2.68 | 2.22 | 2.54 | 1.96 | 1.67 | 1.33 | 1.06 | 0.99 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Krishna Institute of Medical Sciences Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 567 | 664 | 918 | 1,123 | 1,330 | 1,651 | 2,198 | 2,498 | 3,035 | 3,905 | 4,212 |
| Operating profit | 118 | 71 | 85 | 251 | 377 | 524 | 611 | 648 | 793 | 815 | 833 |
| OPM % | 21% | 11% | 9% | 22% | 28% | 32% | 28% | 26% | 26% | 21% | 20% |
| Net profit | 33 | -46 | -49 | 115 | 205 | 344 | 366 | 336 | 415 | 242 | 194 |
| EPS (₹) | 0.91 | -1.32 | -1.28 | 3.20 | 5.19 | 8.32 | 8.41 | 7.75 | 9.61 | 6.03 | 5.05 |
TTM is the trailing twelve months to the most recent quarter.
Krishna Institute of Medical Sciences Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 72 | 50 | 74 | 74 | 78 | 80 | 80 | 80 | 80 | 80 |
| Reserves | 255 | -209 | 466 | 524 | 786 | 1,307 | 1,590 | 1,748 | 2,058 | 2,167 |
| Borrowings | 280 | 753 | 336 | 369 | 316 | 257 | 678 | 1,355 | 2,562 | 4,253 |
| Other liabilities | 167 | 359 | 237 | 228 | 253 | 260 | 553 | 636 | 990 | 1,190 |
| Total liabilities | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,689 | 7,691 |
| Fixed assets | 518 | 755 | 863 | 916 | 931 | 1,005 | 1,766 | 2,434 | 3,348 | 5,710 |
| CWIP | 64 | 0 | 0 | 2 | 9 | 21 | 477 | 600 | 1,214 | 606 |
| Investments | 14 | 0 | 0 | 0 | 0 | 332 | 68 | 157 | 99 | 103 |
| Other assets | 177 | 199 | 250 | 276 | 493 | 546 | 590 | 629 | 1,028 | 1,271 |
| Total assets | 774 | 954 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,689 | 7,691 |
As reported by the company. Total assets equal total liabilities by construction.
Krishna Institute of Medical Sciences Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 82 | 106 | 134 | 202 | 356 | 324 | 432 | 521 | 582 | 511 |
| Cash from investing | -100 | -64 | -110 | -125 | -354 | -412 | -416 | -753 | -1,116 | -1,452 |
| Cash from financing | 24 | -39 | -27 | -44 | 10 | 61 | 20 | 217 | 543 | 940 |
| Net cash flow | 5 | 3 | -3 | 32 | 12 | -26 | 36 | -15 | 9 | -1 |
| Free cash flow | -18 | 49 | 57 | 150 | 262 | 154 | -140 | -125 | -380 | -902 |
| CFO / operating profit | 80% | 192% | 195% | 102% | 104% | 86% | 87% | 102% | 91% | 81% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Krishna Institute of Medical Sciences Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 15% | 11% | 5% | 20% | 29% | 34% | 24% | 17% | 15% | 10% |
| Debtor days | 59 | 59 | 49 | 43 | 30 | 28 | 42 | 43 | 48 | 52 |
| Inventory days | 43 | 46 | 47 | 44 | 30 | 37 | — | — | — | — |
| Days payable | 207 | 215 | 181 | 177 | 167 | 133 | — | — | — | — |
| Cash conversion cycle | -105 | -110 | -85 | -91 | -106 | -67 | 42 | 43 | 48 | 52 |
| Working capital days | 26 | -333 | -15 | -15 | -31 | -3 | 8 | -5 | -29 | -37 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Krishna Institute of Medical Sciences Ltd shareholding pattern
Promoters held 32.49% at Jun 2026, down from 34.11% at Jun 2025. FIIs 14.75% and DIIs 34.42%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 38.82% | 38.82% | 38.82% | 34.11% | 34.11% | 34.11% | 34.11% | 32.49% |
| FIIs | 15.85% | 15.68% | 15.44% | 15.54% | 15.03% | 14.33% | 14.57% | 14.75% |
| DIIs | 32.29% | 32.05% | 31.95% | 31.65% | 32.12% | 32.72% | 32.50% | 34.42% |
| Public | 13.03% | 13.45% | 13.78% | 18.68% | 18.74% | 18.85% | 18.82% | 18.32% |
| No. of shareholders | 77,617 | 95,468 | 1,01,895 | 1,08,955 | 1,04,872 | 1,01,599 | 93,333 | 94,730 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When does Krishna Institute of Medical Sciences Ltd’s board next meet?
Krishna Institute of Medical Sciences Ltd’s board meets on 31 Oct 2026.
- Board meetingApproval of acquisition of 51% stake in Sarvottam Health Care Private Limited
See the full results calendar for every Indian company reporting in the next 30 days.
Krishna Institute of Medical Sciences Ltd corporate filings
- Certificate under Reg. 74(5) of SEBI (DP) Regulations for the quarter ended 30.09.2026Company Updatelow impact
- Krishna Institute of Medical Sciences receives BSE query; no financial or operational details disclosedCompany Updatelow impact
Cruxal's analysis: The company has issued a general update regarding a query received from BSE, with no…
Read the full analysis - Krishna Institute of Medical Sciences Ltd issues general corporate update, no material financial or operational changes reportedCompany Updatelow impact
Cruxal's analysis: The company has released a routine general update without any specific financial results…
Read the full analysis - Krishna Institute of Medical Sciences to acquire up to 22% stake in Splendid Hospitals Private Limited for Rs. 40 crore, signaling strategic expansion into healthcare infrastructureCompany Updatehigh impact
Cruxal's analysis: Krishna Institute of Medical Sciences (KIMS) has announced its intention to acquire up to…
Read the full analysis - Krishna Institute of Medical Sciences to acquire up to 51% stake in Sarvottam Health Care Private Limited for Rs. 80 crore, signaling strategic expansion into healthcare operations.Company Updatehigh impact
Cruxal's analysis: Krishna Institute of Medical Sciences (KIMS) has announced a strategic move to acquire up…
Read the full analysis - Krishna Institute of Medical Sciences to acquire 6% stake in Ushahkal Abhinav Specialty Hospital LLP for ₹15 crore, signaling strategic expansion in healthcare infrastructureCompany Updatehigh impact
Cruxal's analysis: Krishna Institute of Medical Sciences (KIMS) has announced the acquisition of a 6% stake…
Read the full analysis - Krishna Institute of Medical Sciences to acquire up to 51% stake in Insignia Healthcare Private Limited, targeting strategic expansion in healthcare operationsCompany Updatehigh impact
Cruxal's analysis: Krishna Institute of Medical Sciences Limited (KIMS) has approved the acquisition of up…
Read the full analysis - Closure of Trading Window for consideration of unaudited financial results for 2nd Quarter and half-year ending 30th September, 2026.Insider Trading / SASTlow impact
- Krishna Institute of Medical Sciences (KIMS) reports pledge of 2.80 crore shares by promotersInsider Trading / SASTmedium impact
Cruxal's analysis: Krishna Institute of Medical Sciences Limited has disclosed that promoters Bhaskara Rao…
Read the full analysis - Krishna Institute of Medical Sciences Ltd to participate in Anand Rathi G-200 Summit 2026Company Updatelow impact
Cruxal's analysis: Krishna Institute of Medical Sciences Ltd has announced its participation in the Anand…
Read the full analysis - Krishna Institute of Medical Sciences Ltd schedules participation in J.P. Morgan India ConferenceCompany Updatelow impact
Cruxal's analysis: Krishna Institute of Medical Sciences Ltd has announced its participation in the J.P…
Read the full analysis - KIMS enters into Operations and Management Agreement with Sarvottam Health Care Private LimitedCompany Updatelow impact
Cruxal's analysis: Krishna Institute of Medical Sciences (KIMS) has signed an Operations and Management…
Read the full analysis - Krishna Institute of Medical Sciences Ltd announces schedule for Analyst/Institutional Investor meetingCompany Updatelow impact
Cruxal's analysis: Krishna Institute of Medical Sciences Ltd has issued an intimation regarding a scheduled…
Read the full analysis - Krishna Institute of Medical Sciences Limited (KIMS) Announces Voting Results of 24th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Krishna Institute of Medical Sciences Limited has successfully concluded its 24th Annual…
Read the full analysis - Krishna Institute of Medical Sciences Limited (KIMS) Concludes 24th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Krishna Institute of Medical Sciences Limited has successfully concluded its 24th Annual…
Read the full analysis - KIMS clarifies media reports regarding potential $52 million acquisition of Renova HospitalsCompany Updatelow impact
Cruxal's analysis: Krishna Institute of Medical Sciences (KIMS) has issued a clarification regarding a…
Read the full analysis - KIMS enters into Operations and Management and Call Option agreement with Aurevia HospitalsCompany Updatemedium impact
Cruxal's analysis: Krishna Institute of Medical Sciences (KIMS) has signed an Operations and Management…
Read the full analysis - Krishna Institute of Medical Sciences Ltd announces allotment of warrantsCompany Updatelow impact
Cruxal's analysis: The company has completed the formal allotment of warrants as part of its corporate…
Read the full analysis - KIMS Hospitals Q1 FY27 Earnings: Strong Revenue Growth of 36.1% YoY, Debt Reduction via QIP, and Strategic Focus on Operational StabilizationCompany Updatehigh impact
Cruxal's analysis: KIMS Hospitals reported Q1 FY27 revenue of INR 1,196 crore, marking a 36.1% YoY growth…
Read the full analysis - KIMS Hospitals receives in-principle approval for preferential issue of 77.02 lakh warrants to promotersCompany Updatemedium impact
Cruxal's analysis: Krishna Institute of Medical Sciences Limited (KIMS) has secured in-principle approval…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.